Overview
Background
Associate Professor Andy Moore is a Paediatric Oncologist and Director of Research at Children's Health Queensland Hospital & Health Service (CHQ). He is also Director of the Queensland Children's Tumour Bank, a unique resource located on the Queensland Children's Hospital precinct, facilitating local, national and international collaborative research across all childhood cancer types and supporting enrolment of children on clinical trials. A/Prof. Moore's clinical and research interests focus on childhood leukaemia, particularly acute myeloid leukaemia (AML), an aggressive form of leukaemia with a poor prognosis. He also holds a number of leadership and advisory roles, including Deputy Chair of the Australian & New Zealand Childrens Haematology / Oncology Group (ANZCHOG).
Availability
- Dr Andy Moore is:
- Not available for supervision
- Media expert
Fields of research
Qualifications
- Bachelor of Medicine and Surgery and Medical Science, The University of Queensland
- Doctor of Philosophy, University College London
Research interests
-
Acute Myeloid Leukaemia
-
Leukaemia
-
Blood Cancers
-
Paediatric Oncology
-
Childhood Cancer
-
Biobanking
Works
Search Professor Andy Moore’s works on UQ eSpace
2022
Journal Article
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions
Venn, Nicola C., Huang, Libby, Hovorková, Lenka, Muskovic, Walter, Wong, Marie, Law, Tamara, Heatley, Susan L., Khaw, Seong Lin, Revesz, Tom, Dalla Pozza, Luciano, Shaw, Peter J., Fraser, Chris, Moore, Andrew S., Cross, Siobhan, Bendak, Katerina, Norris, Murray D., Henderson, Michelle J., White, Deborah L., Cowley, Mark J., Trahair, Toby N., Zuna, Jan and Sutton, Rosemary (2022). Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions. British Journal of Cancer, 127 (5), 908-915. doi: 10.1038/s41416-022-01806-6
2021
Journal Article
Changes in cancer incidence and survival among Aboriginal and Torres Strait Islander children in Australia, 1997–2016
Youlden, Danny R., Baade, Peter D., McBride, Craig A., Pole, Jason D., Moore, Andrew S., Valery, Patricia C., Young, Angela and Aitken, Joanne F. (2021). Changes in cancer incidence and survival among Aboriginal and Torres Strait Islander children in Australia, 1997–2016. Pediatric Blood and Cancer, 69 (4) e29492, e29492. doi: 10.1002/pbc.29492
2021
Journal Article
Live-3d-cell immunocytochemistry assays of pediatric diffuse midline glioma
Pericoli, Giulia, Ferretti, Roberta, Moore, Andrew S. and Vinci, Maria (2021). Live-3d-cell immunocytochemistry assays of pediatric diffuse midline glioma. Journal of Visualized Experiments, 177 (177) e63091. doi: 10.3791/63091
2021
Journal Article
Invasive fungal disease in children with acute myeloid leukaemia: an Australian multicentre 10‐year review
Yeoh, Daniel K., Moore, Andrew S., Kotecha, Rishi S., Bartlett, Adam W., Ryan, Anne L., Cann, Megan P., McMullan, Brendan J., Thursky, Karin, Slavin, Monica, Blyth, Christopher C., Haeusler, Gabrielle M. and Clark, Julia E. (2021). Invasive fungal disease in children with acute myeloid leukaemia: an Australian multicentre 10‐year review. Pediatric Blood and Cancer, 68 (11) e29275, 1-11. doi: 10.1002/pbc.29275
2021
Journal Article
Childhood acute myeloid leukemia shows a high level of germline predisposition
Samaraweera, Saumya E, Wang, Paul Po-Shen, Li, Ka Leung, Casolari, Debora A., Feng, Jinghua, Pinese, Mark, Maung, Kyaw Ze Ya, Leo, Paul James, Cowley, Mark J., Perkins, Kelly, Smith, Amanda M., Ellis, Jonathan, Wee, Amilia, Hiwase, Devendra K., Scott, Hamish S., Schreiber, Andreas W., Brown, Anna L., Deans, Andrew J., Ross, David M., Moore, Andrew S., Gonda, Thomas, Hahn, Christopher N. and D'Andrea, Richard J. (2021). Childhood acute myeloid leukemia shows a high level of germline predisposition. Blood, 138 (22), 2293-2298. doi: 10.1182/blood.2021012666
2021
Journal Article
Tumor cell invasion into Matrigel: optimized protocol for RNA extraction
Ferretti, Roberta, Baldassarre, Antonella, Billy, Emmanuel de, M Carcaboso, Angel, Moore, Andrew, Carai, Andrea, Mastronuzzi, Angela, Masotti, Andrea and Vinci, Maria (2021). Tumor cell invasion into Matrigel: optimized protocol for RNA extraction. BioTechniques, 70 (6), 327-335. doi: 10.2144/btn-2021-0001
2020
Journal Article
Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer
Wong, Marie, Mayoh, Chelsea, Lau, Loretta M. S., Khuong-Quang, Dong-Anh, Pinese, Mark, Kumar, Amit, Barahona, Paulette, Wilkie, Emilie E., Sullivan, Patricia, Bowen-James, Rachel, Syed, Mustafa, Martincorena, Iñigo, Abascal, Federico, Sherstyuk, Alexandra, Bolanos, Noemi A., Baber, Jonathan, Priestley, Peter, Dolman, M. Emmy M., Fleuren, Emmy D. G., Gauthier, Marie-Emilie, Mould, Emily V. A., Gayevskiy, Velimir, Gifford, Andrew J., Grebert-Wade, Dylan, Strong, Patrick A., Manouvrier, Elodie, Warby, Meera, Thomas, David M., Kirk, Judy ... Cowley, Mark J. (2020). Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer. Nature Medicine, 26 (11), 1742-1753. doi: 10.1038/s41591-020-1072-4
2020
Journal Article
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents
Pearson, Andrew. D. J., Zwaan, C. Michel, Kolb, E. Anders, Karres, Dominik, Guillot, Julie, Kim, Su Young, Marshall, Lynley, Tasian, Sarah K., Smith, Malcolm, Cooper, Todd, Adamson, Peter C., Barry, Elly, Benettaib, Bouchra, Binlich, Florence, Borgman, Anne, Brivio, Erica, Capdeville, Renaud, Delgado, David, Faller, Douglas V., Fogelstrand, Linda, Fraenkel, Paula Goodman, Hasle, Henrik, Heenen, Delphine, Kaspers, Gertjan, Kieran, Mark, Klusmann, Jan-Henning, Lesa, Giovanni, Ligas, Franca, Mappa, Silvia ... Vassal, Gilles (2020). Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents. European Journal of Cancer, 136, 116-129. doi: 10.1016/j.ejca.2020.04.038
2020
Journal Article
Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes
Clarke, Matthew, Mackay, Alan, Ismer, Britta, Pickles, Jessica Chiara, Tatevossian, Ruth G., Newman, Scott, Bale, Tejus A., Stoler, Iris, Izquierdo, Elisa, Temelso, Sara, Carvalho, Diana M., Molinari, Valeria, Burford, Anna, Howell, Louise, Virasami, Alex, Fairchild, Amy R., Avery, Aimee, Chalker, Jane, Kristiansen, Mark, Haupfear, Kelly, Dalton, James D., Orisme, Wilda, Wen, Ji, Hubank, Michael, Kurian, Kathreena M., Rowe, Catherine, Maybury, Mellissa, Crosier, Stephen, Knipstein, Jeffrey ... Jones, Chris (2020). Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes. Cancer Discovery, 10 (7), 942-963. doi: 10.1158/2159-8290.cd-19-1030
2020
Journal Article
Pattern of relapse and treatment response in WNT-activated medulloblastoma
Nobre, Liana, Zapotocky, Michal, Khan, Sara, Fukuoka, Kohei, Fonseca, Adriana, McKeown, Tara, Sumerauer, David, Vicha, Ales, Grajkowska, Wieslawa A, Trubicka, Joanna, Li, Kay Ka Wai, Ng, Ho-Keung, Massimi, Luca, Lee, Ji Yeoun, Kim, Seung-Ki, Zelcer, Shayna, Vasiljevic, Alexandre, Faure-Conter, Cécile, Hauser, Peter, Lach, Boleslaw, van Veelen-Vincent, Marie-Lise, French, Pim J, Van Meir, Erwin G, Weiss, William A, Gupta, Nalin, Pollack, Ian F, Hamilton, Ronald L, Nageswara Rao, Amulya A, Giannini, Caterina ... Ramaswamy, Vijay (2020). Pattern of relapse and treatment response in WNT-activated medulloblastoma. Cell Reports Medicine, 1 (3) 100038, 100038. doi: 10.1016/j.xcrm.2020.100038
2020
Journal Article
Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736
Moore, Andrew S., Faisal, Amir, Mak, Grace W. Y., Miraki-Moud, Farideh, Bavetsias, Vassilios, Valenti, Melanie, Box, Gary, Hallsworth, Albert, de Haven Brandon, Alexis, Xavier, Cristina P. R., Stronge, Randal, Pearson, Andrew D. J., Blagg, Julian, Raynaud, Florence I., Chopra, Rajesh, Eccles, Suzanne A., Taussig, David C. and Linardopoulos, Spiros (2020). Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736. Blood Advances, 4 (7), 1478-1491. doi: 10.1182/bloodadvances.2019000986
2020
Journal Article
Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 children
Uden, Theodor, Bertaina, Alice, Abrahamsson, Jonas, Ansari, Marc, Balduzzi, Adriana, Bourquin, JeanPierre, Gerhardt, Corinne, Bierings, Marc, Hasle, Henrik, Lankester, Arjan, Mischke, Kirsten, Moore, Andrew S., Nivison-Smith, Ian, Pieczonka, Anna, Peters, Christina, Sedlacek, Petr, Reinhardt, Dirk, Stein, Jerry, Versluys, Birgitta, Wachowiak, Jacek, Willems, Leen, Zimmermann, Martin, Locatelli, Franco and Sauer, Martin G. (2020). Outcome of children relapsing after first allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: a retrospective I-BFM analysis of 333 children. British Journal of Haematology, 189 (4) bjh.16441, 745-750. doi: 10.1111/bjh.16441
2020
Journal Article
Second primary cancers in people who had cancer as children: an Australian Childhood Cancer Registry population-based study
Youlden, Danny R., Baade, Peter D., Green, Adèle C., Valery, Patricia C., Moore, Andrew S. and Aitken, Joanne F. (2020). Second primary cancers in people who had cancer as children: an Australian Childhood Cancer Registry population-based study. Medical Journal of Australia, 212 (3) mja2.50425, 121-125. doi: 10.5694/mja2.50425
2020
Journal Article
Erratum: PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors (Oncotarget (2019) 10 (5755-5767) DOI: 10.18632/oncotarget.27206)
Smith, Amanda M., Zhang, Christine R.C., Cristino, Alexandre S., Grady, John P., Lynn Fink, J. and Moore, Andrew S. (2020). Erratum: PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors (Oncotarget (2019) 10 (5755-5767) DOI: 10.18632/oncotarget.27206). Oncotarget, 11 (3), 305-305. doi: 10.18632/oncotarget.27402
2019
Journal Article
PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors
Smith, Amanda M., Zhang, Christine R.C., Cristino, Alexandre S., Grady, John P., Fink, Lynn J. and Moore, Andrew S. (2019). PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors. Oncotarget, 10 (56), 5755-5767. doi: 10.18632/oncotarget.27206
2019
Journal Article
Invasive fungal infections in children with acute lymphoblastic leukaemia: results from four Australian centres, 2003‐2013
Wang, Stacie S., Kotecha, Rishi S., Bernard, Anne, Blyth, Christopher C., McMullan, Brendan J., Cann, Megan P., Yeoh, Daniel K., Bartlett, Adam W., Ryan, Anne L., Moore, Andrew S., Bryant, Penelope A., Clark, Julia and Haeusler, Gabrielle M. (2019). Invasive fungal infections in children with acute lymphoblastic leukaemia: results from four Australian centres, 2003‐2013. Pediatric Blood and Cancer, 66 (10) e27915, e27915. doi: 10.1002/pbc.27915
2019
Journal Article
Hematopoietic stem cell transplantation for children with acute myeloid leukemia in second remission: a report from the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children's Haematology Oncology Group
Selim, Adrian, Alvaro, Frank, Cole, Catherine H., Fraser, Chris J., Mechinaud, Francoise, O'Brien, Tracey A., Shaw, Peter J., Tapp, Heather, Teague, Lochie, Nivison‐Smith, Ian and Moore, Andrew S. (2019). Hematopoietic stem cell transplantation for children with acute myeloid leukemia in second remission: a report from the Australasian Bone Marrow Transplant Recipient Registry and the Australian and New Zealand Children's Haematology Oncology Group. Pediatric Blood & Cancer, 66 (8) e27812, e27812. doi: 10.1002/pbc.27812
2019
Journal Article
Stage at diagnosis for children with blood cancers in Australia: Application of the Toronto Paediatric Cancer Stage Guidelines in a population-based national childhood cancer registry
Youlden, Danny R., Gupta, Sumit, Frazier, A. Lindsay, Moore, Andrew S., Baade, Peter D., Valery, Patricia C., Green, Adèle C. and Aitken, Joanne F. (2019). Stage at diagnosis for children with blood cancers in Australia: Application of the Toronto Paediatric Cancer Stage Guidelines in a population-based national childhood cancer registry. Pediatric Blood and Cancer, 66 (6) e27683, e27683. doi: 10.1002/pbc.27683
2019
Journal Article
ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma
Carvalho, Diana, Taylor, Kathryn R., Olaciregui, Nagore Gene, Molinari, Valeria, Clarke, Matthew, Mackay, Alan, Ruddle, Ruth, Henley, Alan, Valenti, Melanie, Hayes, Angela, Brandon, Alexis De Haven, Eccles, Suzanne A., Raynaud, Florence, Boudhar, Aicha, Monje, Michelle, Popov, Sergey, Moore, Andrew S., Mora, Jaume, Cruz, Ofelia, Vinci, Mara, Brennan, Paul E., Bullock, Alex N., Carcaboso, Angel Montero and Jones, Chris (2019). ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine glioma. Communications Biology, 2 (1) 156, 156. doi: 10.1038/s42003-019-0420-8
2019
Journal Article
The Australian and New Zealand Children's Haematology/Oncology Group Biobanking Network
Boutros, Rose, Catchpoole, Daniel, Collins, Kiri, Cross, Siobhan, Downie, Peter, Drinkwater, Caroline, Fletcher, Jamie, Gottardo, Nicholas, Hunter, Sarah, Kirby, Maria, Ludlow, Louise, Macnish, Marion, Maybury, Mellissa, Moore, Andrew, Morrin, Helen, Purdy, Sarah, Revesz, Tamas, Saffery, Richard, Strong, Robyn, Trahair, Toby, Wood, Andrew and Byrne, Jennifer (2019). The Australian and New Zealand Children's Haematology/Oncology Group Biobanking Network. Biopreservation and Biobanking, 17 (2), 95-97. doi: 10.1089/bio.2019.0013
Funding
Current funding
Past funding
Supervision
Availability
- Dr Andy Moore is:
- Not available for supervision
Supervision history
Completed supervision
-
2020
Doctor Philosophy
Characterisation of the MLL fusion transcriptome in childhood leukaemia
Principal Advisor
-
Doctor Philosophy
Aminopeptidase Inhibition as a Potential Therapeutic Strategy for Acute Myeloid Leukaemia
Principal Advisor
Media
Enquiries
Contact Dr Andy Moore directly for media enquiries about:
- Childhood Cancer
- Childhood Leukaemia
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: